Tiziana Life Sciences Ltd

NASDAQ: TLSA · Real-Time Price · USD
1.90
-0.07 (-3.55%)
At close: Aug 18, 2025, 3:59 PM
1.95
2.85%
After-hours: Aug 18, 2025, 06:18 PM EDT

Tiziana Life Sciences Ltd Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-17.98M -14.59M -27.37M
Interest Income
1.15M n/a n/a
Pretax Income
-17.24M -15.4M -26.66M
Net Income
-17.69M -15.4M -23.42M
Selling & General & Admin
n/a n/a 855K
Research & Development
8.11M 12.96M 13.21M
Other Expenses
9.87M 1.63M 13.31M
Operating Expenses
17.98M 14.59M 27.37M
Interest Expense
10K 7K 176K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
17.98M 14.59M 27.37M
Income Tax Expense
449K n/a -3.24M
Shares Outstanding (Basic)
50.76M 50.76M 48.97M
Shares Outstanding (Diluted)
50.76M 50.76M 48.97M
EPS (Basic)
-0.34 -0.3 -0.48
EPS (Diluted)
-0.34 -0.3 -0.48
EBITDA
-17.14M -15.34M -26.34M
EBIT
-17.23M -15.39M -26.48M
Depreciation & Amortization
96K 51K 141K